ENTRY       D09897                      Drug
NAME        Enokizumab (USAN/INN)
FORMULA     C6496H10000N1704O2038S44
EXACT_MASS  145895.8955
MOL_WEIGHT  145985.9612
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGSSVKV SCKASGGTFS YYWIEWVRQA PGQGLEWMGE ILPGSGTTNP
            NEKFKGRVTI TADESTSTAY MELSSLRSED TAVYYCARAD YYGSDYVKFD YWGQGTLVTV
            SSASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ
            SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSNTKVDKRV EPKSCDKTHT CPPCPAPELL
            GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ
            YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR
            EEMTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS
            RWQQGNVFSC SVMHEALHNH YTQKSLSLSP GK
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCKASQHVI THVTWYQQKP GKAPKLLIYG TSYSYSGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ FYEYPLTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H149-H205, H266-H326, H372-H430, H231-H'231, 234-H'234, L23-L88, L134-L194, H225-L214)
  TYPE      Peptide
CLASS       Immunological agent
             DG02019  Interleukin inhibitor
EFFICACY    Antiasthmatic, Anti-IL-9 antibody
  TYPE      Monoclonal antibody
TARGET      IL9 [HSA:3578] [KO:K05432]
  PATHWAY   hsa04060(3578)  Cytokine-cytokine receptor interaction
            hsa04630(3578)  JAK-STAT signaling pathway
            hsa05310(3578)  Asthma
BRITE       Drug groups [BR:br08330]
             Immunological agent
              DG02019  Interleukin inhibitor
               D09897  Enokizumab
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Interleukins
                IL9
                 D09897  Enokizumab (USAN/INN)
DBLINKS     CAS: 909875-08-7
            PubChem: 124490610
///
